Who is sponsoring NCT03908996?

NCT03908996 is sponsored by Sanford Health.

What drugs are being tested in NCT03908996?

Interventions in NCT03908996: Profile by Sanford weight management plan.

What condition does NCT03908996 study?

NCT03908996 studies Endometrial Cancer, Overweight.

Is NCT03908996 still recruiting?

NCT03908996 is currently completed. Last updated 18 March 2021.

Last reviewed 2021-03-18 · How we verify

NCT03908996

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer

Completed NA Last updated 18 March 2021

What this trial tests

NA trial testing Profile by Sanford weight management plan in Endometrial Cancer in 25 participants. Completed in 11 January 2021.

Timeline

11 February 2019

Primary endpoint
11 January 2021

11 January 2021

Quick facts

Lead sponsor	Sanford Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	25
Start date	11 February 2019
Primary completion	11 January 2021
Estimated completion	11 January 2021
Sites	2 locations across United States

Drugs / interventions tested

Profile by Sanford weight management plan

Conditions studied

Endometrial Cancer — all drugs for Endometrial Cancer →
Overweight — all drugs for Overweight →

Sponsor

Sanford Health — full company profile →

Who can join

18 and older, female only, with Endometrial Cancer or Overweight. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary purpose of this study is to evaluate the effectiveness of a 12-month comprehensive weight management program on weight change in overweight/obese patients following treatment for endometrial cancer. During the study period, subjects will be monitored for recurrence during routine clinic visits A secondary exploratory purpose of this study will be to evaluate the gut microbiome in this intervention group and the changes that may occur while participating in a weight loss and weight management program.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

How the Gut Microbiome Links to Menopause and Obesity, with Possible Implications for Endometrial Cancer Development.
Schreurs MPH, de Vos van Steenwijk PJ, Romano A, Dieleman S, et al · · 2021 · cited 38× · PMID 34209916 · DOI 10.3390/jcm10132916

Verify or expand the search:

Other recruiting trials for Endometrial Cancer

Currently open trials in the same condition.

NCT07419841 — A Phase 1 Study of the Safety and Tolerability of CTX-10726 · Phase 1 · recruiting
NCT07382583 — Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the P · recruiting
NCT07377734 — Intrauterine Injection of Type III Collage in FST of EC/AEH · Phase 2 · recruiting
NCT07319429 — Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification · Phase 2, PHASE3 · recruiting
NCT07397624 — Endoscopic Suture Gastroplasty (ESG) for Treatment of Obese Patients With Endometrial Cancer · recruiting

Other Sanford Health trials

Trials by the same sponsor.

NCT06883266 — Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD · NA · recruiting
NCT06524349 — Utilization of a 3D Printed Customized Knee Extender and At-Home Rehabilitation Program on Patient Outcomes Following AC · NA · active not recruiting
NCT06008561 — Midwest Birth Outcomes and Indigenous American Pregnancy · recruiting
NCT05798377 — Maternal Stress and Blood Sugar Metabolization · active not recruiting
NCT05671913 — Scheduled Intranasal Ketamine · EARLY_PHASE1 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03908996 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sanford Health
Last refreshed: 18 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03908996.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing